Satellos Bioscience (MSLE) vs Minerva Neurosciences (NERV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Minerva Neurosciences (NERV) has outperformed Satellos Bioscience (MSLE) over the past year, gaining 50.0% versus a gain of 5.4%. Over five years, MSLE leads with a -48.9% price change compared with -69.7% for NERV. Satellos Bioscience is the larger company by market cap ($161.9 million vs $156.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MSLE | NERV |
|---|---|---|
| Share price | $7.63 | $3.27 |
| Market cap | $161.88M | $156.13M |
| 1-day change | +1.19% | -4.66% |
| YTD return | +29.76% | -18.66% |
| 1-year return | +5.44% | +50.00% |
| 5-year return | -48.93% | -69.72% |
| EPS (TTM) | $-1.95 | $-34.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.40 | $12.46 |
| 52-week low | $5.30 | $2.24 |
| Distance from 52-week high | -43.04% | -73.76% |
| Average volume | 51.35K | 185.68K |
| Shares outstanding | 21.22M | 47.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NERV has outperformed MSLE by 44.6 percentage points over the past year.
MSLE vs NERV FAQ
Which is bigger, Satellos Bioscience or Minerva Neurosciences?
Satellos Bioscience (MSLE) is larger, with a market capitalization of $161.88M compared with $156.13M for Minerva Neurosciences (NERV).
Which stock has performed better over the past year, MSLE or NERV?
NERV returned +50.00% over the past 12 months, compared with +5.44% for MSLE (price return, excluding dividends). Past performance does not predict future results.
Are Satellos Bioscience and Minerva Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.